Position in IMMP
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$157,342
-$1,142,242 QoQ
Shares Held
449,550
-1.1% QoQ
Ownership
0.305%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
10 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in IMMP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Meridian Wealth Management, LLC holds $7,258,442 across 7 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
22,028 | $5,391,793 | |
| 2 | NUVB |
Nuvation Bio Inc.
|
132,256 | $751,214 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
742 | $368,573 | |
| 4 | DMAC |
DiaMedica Therapeutics Inc.
|
43,600 | $306,944 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
801 | $253,188 | |
| 6 | NMRA |
Neumora Therapeutics, Inc.
|
94,400 | $160,480 | |
| 7 | BYSI |
BeyondSpring Inc.
|
15,000 | $26,250 |
All Filings in IMMP
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $157,342 | 449,550 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,299,584 | 454,400 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $736,575 | 420,900 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $611,228 | 372,700 | Shares | Sole | 2025-08-08 | |
| 2024-12-31 | $855,305 | 394,150 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $880,574 | 398,450 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $766,212 | 381,200 | Shares | Sole | 2024-08-08 | |
| 2023-12-31 | $773,880 | 322,450 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $591,280 | 311,200 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $555,035 | 263,050 | Shares | Sole | 2023-08-02 | |
| No filing history on record for this holder in this stock. | ||||||